Loading clinical trials...
Loading clinical trials...
BURAN: Effects of Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging Parameters
Conditions
Interventions
Benralizumab
Locations
25
United States
Research Site
Walnut Creek, California, United States
Research Site
Loxahatchee Groves, Florida, United States
Research Site
Plantation, Florida, United States
Research Site
Greenwood, Indiana, United States
Research Site
Lexington, Kentucky, United States
Research Site
St Louis, Missouri, United States
Start Date
October 11, 2022
Primary Completion Date
July 19, 2024
Completion Date
July 19, 2024
Last Updated
March 25, 2025
NCT06979323
NCT06664619
NCT07431021
NCT07383896
NCT07282886
NCT07356310
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions